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DBackground: In adults with right-sided congenital heart disease, vasoplegia during and after cardiopulmonary
bypass appears to be a frequent complication. The incidence of vasoplegia in the general adult and pediatric car-
diac surgical population has been investigated, but the incidence in adult patients with right-sided congenital
heart disease is unknown. Perioperative vasopressin levels during cardiac surgery have been studied in other car-
diac surgical patients, but are not known in adults with right-sided congenital heart disease. The purpose of this
study was to investigate the incidence of vasoplegia in adult patients undergoing right-sided cardiac surgical pro-
cedures requiring cardiopulmonary bypass and to determine the vasopressin response to cardiac surgery in this
population.
Methods: Twenty patients were enrolled and demographic, hemodynamic, cardiopulmonary bypass, and use of
vasoactive medication data were collected. In addition, perioperative serum vasopressin levels were measured.
Sixty adult patients undergoing left-sided cardiac surgery served as controls.
Results: The incidence of vasoplegia in the control patients was 10% and the incidence in the adult patients with
right-sided congenital heart disease was 20%. Vasopressin levels were low at baseline (0.5  0.5 pg/mL),
increased slightly after induction of anesthesia (0.6 0.6 pg/mL), increased after initiation of cardiopulmonary
bypass (99.7  168.2 pg/mL), and decreased after surgery (31.3  43.6 pg/mL).
Conclusions: This study showed that the incidence of vasoplegia (20%) in patients with right-sided congenital
heart disease undergoing cardiac surgery was double that of a population of patients undergoing aortic valve
surgery (10%). Serum vasopressin concentration was not associated with vasoplegia in this population of
congenital cardiac surgical patients. (J Thorac Cardiovasc Surg 2014;148:625-30)Vasoplegia has been well described after surgery requiring
cardiopulmonary bypass (CPB) as well as during off-pump
coronary artery bypass grafting and is defined by hypoten-
sion in the setting of low systemic vascular resistance with
normal or increased cardiac output.1 The incidence of vaso-
plegia in adults undergoing cardiac surgery is between 5%
and 25%.2 Vasoplegia has been associated with increased
intensive care unit length of stay and hospital length of
stay.1,3,4 The type of surgery may influence the
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The Journal of Thoracic and Cabeen shown to have a higher occurrence of vasoplegia
compared with coronary artery bypass grafting.2
In addition, patients with right-sided congenital heart dis-
ease are also at risk for hepatic congestion and subsequent
hepatic dysfunction, which may result in a vasodilated hy-
perdynamic state. Vasoplegia has been investigated in pa-
tients undergoing a variety of cardiac surgeries, but
patients with right-sided congenital heart disease including
tetralogy of Fallot have not been studied previously. Anec-
dotally, in our practice there appeared to be a higher inci-
dence of vasoplegia in patients with right-sided congenital
cardiac valvular disease undergoing repair using CPB as
compared with other cardiac surgical procedures.
Low levels of vasopressin may contribute to vasodilatory
shock after cardiac surgery.5 In patients without vasoplegia,
vasopressin levels have been shown to increase on bypass,
decrease after CPB, and then increase again, and postoper-
ative hypertension is associated with increased levels of
vasopressin.6 In patients undergoing cardiac surgery, an
average amount of vasopressor or inotropic support is not
known and different practices use a variety of medications
for hemodynamic support. The purpose of the current
article is to describe the incidence of vasoplegia in adults
with right-sided congenital valve disease undergoingrdiovascular Surgery c Volume 148, Number 2 625
Abbreviations and Acronyms
ACE-I ¼ angiotensin-converting enzyme inhibitor
ARB ¼ angiotensin II receptor blocker
CPB ¼ cardiopulmonary bypass
CVP ¼ central venous pressure
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Dsurgical repair as compared with patients with left-sided
valve disease. We hypothesized that the incidence of vaso-
plegia in this population would be higher than in the general
cardiac surgical population and possibly would be associ-
ated with an underlying vasopressin deficiency.
METHODS
After institutional review board approval and verbal consent, patients
with right-sided congenital heart disease undergoing surgical procedures
requiring CPB were enrolled and prospectively evaluated for the occur-
rence of vasoplegia and levels of vasopressin were measured. These levels
were compared with hemodynamics during CPB for potential correlation
with hypotension during bypass. Assuming that the true incidence of vaso-
plegia in the general cardiac surgical population is between 10% and 15%,
20 patients were enrolled. Also after institutional review board approval, a
chart review was performed on 60 patients undergoing left-sided cardiac
surgical procedures requiring CPB to determine the incidence of vasople-
gia in this cardiac surgical population and to establish the dose of vaso-
pressor associated with vasoplegia on CPB.
Inclusion/Exclusion Criteria
Patients older than the age of 18 years presenting for cardiac surgery at
the Mayo Clinic (Rochester, Minn) were considered for inclusion. Patients
were eligible for inclusion if they had a diagnosis of tetralogy of Fallot, pul-
monary atresia, Ebstein’s anomaly, or other congenital cardiac disease with
primary involvement of the right-sided cardiac valves. Patients undergoing
surgeries not requiring CPB were excluded, as were patients with other
causes of vasodilatory shock including sepsis. Subjects were recruited in
the Cardiovascular Surgery Clinic in cooperation with the cardiovascular
surgeons and the Anesthesia Clinical Research Unit.
To evaluate the range of vasopressor use in a similar adult cardiac surgical
population, 60 consecutive patients who had undergone left-sided, noncon-
genital cardiac surgical procedures were reviewed retrospectively to serve
as a control group. As the patients with right-sided congenital heart disease
underwent pulmonary valve replacement/repairs with some having right ven-
tricular outflow tract repairs performed, adult patients undergoing left-sided
cardiac surgical procedures including aortic valve replacement/repair and/or
ascending aorta replacement/repairs were included. Patients undergoing cor-
onary artery bypass grafting were excluded because differences in the inci-
dence of vasoplegia have been shown in patients undergoing valvular
surgery versus coronary artery bypass grafting.2 Patients were included if
the surgical procedure also included mitral valve replacement or repair, left
atrial appendage ligation, or pulmonary vein isolation. Patients requiring hy-
pothermic circulatory arrest, descending aortic repair or replacement, or
right-sided cardiac procedures were excluded from this control group.
Cardiopulmonary Bypass Management
The cannulation sites for CPBwere at the discretion of the cardiac surgeon
and dependent on the surgery. The aorta was cannulated with a patient size-
appropriate cannula. Venous cannulation was obtained with either a single
2-stage cannula in the right atrium or separate cannulae in the superior and
inferior vena cavae. Anticoagulation was initiated with 400 U/kg of heparin
andmaintained according to anactivatedclotting time (iSTAT1;Abbott Labs,626 The Journal of Thoracic and Cardiovascular SurgAbbott Park, Ill) of more than 500 seconds. Perfusion during CPB used non-
pulsatile flowwith Sarns 9000 (TerumoCardiovascular Systems, AnnArbor,
Mich) CPB equipment and a Terumomembrane oxygenator. This equipment
uses a hydrophilic interface between the blood and tubing. Smaller circuitry
and oxygenators were used for patients with a body surface less than 2.0 m2.
The CPB circuit was primed with 1000 to 1400 mL of Plasmalyte (Baxter
Healthcare, Deerfield, Ill), mannitol (50 g), albumin (25 g), and heparin
(10,000 U). CPB flows were maintained at 2.4 L/min/m2. Mean arterial pres-
surewasmaintained at 60 to 80mmHg during CPB. For patients undergoing
aortic cross-clamping, hyperkalemic cold blood cardioplegiawas given every
20 to 30 minutes for myocardial protection. Cardioplegia consisted of blood
mixed with crystalloid components in a ratio of 4 parts blood to 1 part crys-
talloid. The crystalloid component consistedof lactatedRingers solutionwith
50mEq/L of sodium bicarbonate and either 100mEq/L (for induction of car-
diac arrest) or 50 mEq/L (for maintenance of cardiac arrest) of potassium.
Warm, potassium-free restorative cardioplegia was not administered before
cross-clamp removal.
Anesthetic Management
Care of these cardiac surgical patients including invasive hemodynamic
monitoring and vasoactive medication administration was driven largely by
institutional protocols. General anesthesia was induced with propofol or ke-
tamine.Anesthesiawasmaintainedwith isoflurane, fentanyl,midazolam, and
vecuronium for neuromuscular blockade. Glucose was measured after CPB
was commenced and at 30- to 60-minute intervals thereafter. Per institutional
protocol, glucose values greater than 180 mg/dL were treated with an insulin
infusion. Transfusion administrationwas guided by a departmental algorithm
with defined transfusion triggers. Administration of inotropic agents or vaso-
pressors were recorded in the anesthesia record as per usual practice.
Laboratory Draws
Study patients underwent 5 blood draws that were performed via pre-
existing intravascular access. The baseline blood samples for study levels
were drawn either after placement of an intravenous or arterial line before
or immediately after anesthesia induction. The second blood draw was ob-
tained 30 minutes after anesthesia induction or 30 minutes after the base-
line blood sample. The third blood draw was performed 30 minutes after
the institution of CPB; the fourth blood draw was performed 30 minutes af-
ter weaning from bypass; and the fifth blood draw was performed 24 hours
after the end of surgery.
Demographic data were obtained including age, sex, height, weight, and
sternotomy number. Liver congestion was assessed by recording liver func-
tion tests if performed, the presence of ascites, and baseline central venous
pressure (CVP).
Outcomes
The primary outcome was the incidence of vasoplegia during CPB (as-
sessed from the need for vasopressors) and the correlation between plasma
levels of vasopressin and vasoplegia during CPB. Our practice is not to use
pulmonary artery catheters in this population of patients with right-sided
congenital cardiac disease, however, per our routine, patients on CPB
were maintained with a cardiac index of 2.4 L/min/m2. This provided a
constant cardiac index and vasoplegia could be ascertained from the use
of vasopressors to treat patients while on CPB. Phenylephrine was the first
vasopressor administered for low mean arterial pressure on CPB, followed
by vasopressin if needed. To determine a control vasopressor dose, 60 pa-
tients undergoing left-sided cardiac surgical procedures as described earlier
were assessed retrospectively for total vasopressor use on CPB and CPB
duration. A vasoplegia incidence of 10% to 15% could be expected
from previous literature descriptions. The phenylephrine dose in milli-
grams was added to the vasopressin dose in units and this valuewas divided
by the duration of CPB in minutes (vasopressor/CPB duration ratio). To
determine those with vasoplegia, a cut-off ratio was calculated from theery c August 2014
Wittwer et al Congenital Heart Diseasemean ratio plus one standard deviation. Additional outcomes measured
were mortality during hospitalization, cerebrovascular accident, renal fail-
ure requiring dialysis of any duration, myocardial infarction, respiratory
failure after extubation requiring noninvasive ventilation or re-intubation,
and postoperative infections.
Data Analysis
Values of plasma vasopressin levels were expressed as the mean stan-
dard deviation. Values were compared between the vasoplegic group and
the nonvasoplegic group using the Student t test. A P value less than .05
was considered significant.C
H
DRESULTS
Twenty patients with right-sided congenital heart disease
completed the study. Baseline demographic information is
shown in Table 1. There were 11 men and 9 women, and
their mean age was 31.2  10.9 years of age. Sixteen of
the 20 patients underwent repairs related to tetralogy of Fal-
lot. Only 1 patient was undergoing a primary sternotomy,
with the remainder undergoing repeat sternotomies (mean
sternotomy number, 2.7  1.3; range, 1-4). Vasopressin
levels for the 20 patients are shown in Figure 1.
Sixty patients undergoing elective left-sided aortic
valvular procedures were evaluated to assess the use of
vasopressors and the incidence of vasoplegia in this popula-
tion and to determine a vasoplegic versus nonvasoplegic
vasopressor/CPB duration ratio. This population included
37 men (62%), with an average age of 68.5  13.8 years.
Other demographics included mean sternotomy number
(1.2  0.6) and mean CPB duration (78.0  32 min).
Figure 2, A, shows the vasopressor/CPB duration ratios for
these 60 patients. Themean ratio plus one standard deviation
(0.07 þ 0.15) was 0.22. Thus, a vasopressor/CPB ratio of
0.22 or less was used to indicate no vasoplegia, and a ratio
greater than 0.22 was used to indicate the presence of
vasoplegia. Six of the 60 patients had vasopressor/CPB
ratios greater than 0.22, yielding a vasoplegia incidence of
10% in this population of cardiac surgical patients.
The vasopressor/CPB duration ratio was calculated in
the 20 congenital patients (Figure 2, B). By using the pre-
viously determined ratio of greater than 0.22 as an indicatorTABLE 1. Demographics of vasoplegic and nonvasoplegic patients with
nonvasoplegic noncongenital patients who underwent left-sided cardiac su
Congenital vasoplegic
patients (N ¼ 4)
Congenital
patient
Male patients, N (%) 3 (75%) 8 (
Age, mean  SD (y) 25  7 33
Height, mean  SD (cm) 170  6 168
Weight, mean  SD (kg) 73  17 77
Sternotomy number, mean  SD 2.0  0 2.8
CPB duration, mean  SD, min 60  34 61
Antihypertensive use, N (%) 1 (25%) 5 (
ACE-I or ARB use, N (%) 0 1
N, Number of patients; SD, standard deviation; CPB, cardiopulmonary bypass; ACE-I, an
The Journal of Thoracic and Caof vasoplegia, 4 of the 20 patients (20%) were deemed vas-
oplegic during CPB. When comparing the vasoplegic
congenital patients with the nonvasoplegic congenital pa-
tients there were no difference between the patient demo-
graphics or plasma vasopressin levels at the baseline,
second, fourth, and fifth blood draws (Tables 1 and 2).
There was a statistically significant difference between
the vasoplegic and nonvasoplegic patients during the
third blood draw, which occurred 30 minutes after
initiating CPB, with the vasoplegic patients having higher
levels of vasopressin owing to exogenous vasopressin
administration (Table 2). Differences in ascites, liver func-
tion tests, and CVP were examined in patients with and
without vasoplegia. One patient in each group was reported
to have ascites and the baseline CVP values were not
different between the groups. Liver function tests were
measured in less than half of the patients and there was
no difference in values between the 2 groups (data not
shown).
There were significant demographic differences between
the patients with congenital heart disease and the patients
undergoing left-sided cardiac surgical procedures. On
average, the patients with congenital heart disease were
younger, had more sternotomies performed, and had shorter
durations on CPB. Patients undergoing left-sided cardiac
surgical procedures had a higher incidence of antihyperten-
sive use, including a higher incidence of angiotensin-
converting enzyme inhibitor (ACE-I) and angiotensin II
receptor blocker (ARB) use compared with the patients
with congenital heart disease (Table 1). The difference
between ACE-I and ARB use was not statistically different
between congenital patients with and without vasoplegia. In
the patients undergoing left-sided procedures the use of an
ACE-I or ARB was not statistically different between the
vasoplegic and nonvasoplegic patients, however, the use
of any form of antihypertensive therapy was higher in vaso-
plegic patients (P<.05). Hemoglobin levels, temperature,
glucose values, and incidence of hyperglycemia treatment
on cardiopulmonary bypass as well as measures of clinical
outcomes for the different groups can be seen in Table 3. Inright-sided congenital heart disease compared with vasoplegic and
rgical procedures
nonvasoplegic
s (N ¼ 16)
Left-sided vasoplegic
patients (N ¼ 6)
Left-sided nonvasoplegic
patients (N ¼ 54)
50%) 5 (83%) 32 (59%)
 11 62  19 69  13
 10 176  8 170  11
 19 113  34 87  25
 1.4 1  0 1  0
 23 68  28 79  33
31%) 6 (100%) 39 (72%)
(6%) 4 (67%) 25 (46%)
giotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.
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FIGURE 1. Laboratory blood draw time points and vasopessin levels.
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Dthe first 24 hours after surgery, therewas no difference in the
use of inotropic or vasopressor agents between the vasople-
gic and nonvasoplegic right-sided congenital heart disease
patients.DISCUSSION
The key findings of this study are that the incidence of
vasoplegia during CPB in patients undergoing right-sided
congenital valve surgery is 2 times that of patients undergo-
ing left-sided cardiac surgery. This increased incidence of
vasoplegia does not appear to be caused by a deficiency
of endogenous vasopressin.
Multiple factors may influence the development of vaso-
plegia. Blood pressure and vascular control ismultifactorial,
with humoral factors working together and in opposition to
ultimately result in vascular tone. Vasopressin causes
vasoconstriction by acting at the vasopressin 1 receptor afterFIGURE 2. A and B, Total vasopressor dose per cardiopulmonary bypass
duration ratio.
628 The Journal of Thoracic and Cardiovascular Surgbeing synthesized in the hypothalamus and released from
the pituitary gland.7,8 In a study comparing 33 patients
with vasodilatory shock with 10 patients without shock
after cardiac surgery, vasopressin levels were lower in
patients with vasodilatory shock on the first postoperative
day, whereas by the third postoperative day the
vasopressin levels were higher in the group with
vasodilatory shock than in the control group.5
Normal values of vasopressor use on CPB were not avail-
able in the literature even though previous investigators had
selected their own cut-off values for inotrope and vaso-
pressor use to qualify for vasoplegia, specifically 4 U/h or
more of vasopressin.9 The mean vasopressor use/CPB dura-
tion plus one standard deviation (0.22) was used as the
cut-off value for vasoplegia in this study based on the anal-
ysis of 60 patients undergoing left-sided cardiac surgery.
This value fit graphically with the data as well as provided
a 10% incidence of vasoplegia, which is consistent with
previous literature (Figure 2). The 6 patients who were in
the vasoplegic category received the equivalent of 4 U/h
or more of vasopressin or very high doses of phenylephrine
on CPB. This is consistent with the definition of vasoplegia
used in the studymentioned previously.9When this method-
ology was applied to the right-sided congenital heart
disease patients, a 20% incidence of vasoplegia was calcu-
lated. This supports our hypothesis that patients undergoing
right-sided congenital heart surgery have a higher incidence
of vasoplegia: twice that of our left-sided aortic valve
replacement or repair population.
The source of an increase in vasoplegia in patients with
right-sided congenital heart disease is not known. Several
factors may influence the high incidence of vasoplegia in
this population including age or a relative overproduction
of vasodilating mediators or underproduction of vasocon-
stricting mediators. Although we noted an increase in vaso-
plegia in these patients, it is interesting to note that
reoperation has been reported to be protective against vaso-
plegia.9 Even with an increase in this potentially protective
factor, an increased percentage of these patients were vaso-
plegic. It is also of interest that the congenital heart disease
patients had a higher incidence of vasoplegia despite a
lower use of ACE-Is or ARBs, medications that have been
associated with vasoplegia.9
Our second hypothesis was that patients with right-sided
congenital heart disease may suffer from liver congestion,
causing a vasodilatory state, or a deficiency in vasopressin
could be resulting in hypotension, however, there was no
statistically significant difference in CVP, presence of asci-
tes, or liver function tests between the patients with vasople-
gia versus those without vasoplegia. In addition, aside from
the third blood sample, there was no difference in vaso-
pressin levels before, during, or after surgery between those
with vasoplegia and those without. The third blood sample
showed a significant difference between vasopressin levelsery c August 2014
TABLE 2. Mean vasopressin levels for all right-sided congenital heart disease patients and levels for the nonvasoplegic versus vasoplegic patients
Vasopressin levels (pg/mL)
All congenital
patients (N ¼ 20)
Vasoplegic
patients (N ¼ 4)
Nonvasoplegia
patients (N ¼ 16)
Vasoplegic versus
nonvasoplegic patients
Mean ± SD Mean ± SD Mean ± SD P value
Baseline blood draw 0.5  0.5 0.5  0.6 0.5  0.5 1
Second blood draw 0.6  0.6 0.3  0.3 0.6  0.6 .4
Third blood draw 99.7  168.2 302.8  220.9 45.6  105.0 .003
Fourth blood draw 40.6  32.9 52.3  38.6 38.4  32.7 .5
Fifth blood draw 31.3  43.6 77.5  88.4 22.9  35.6 .1
The baseline blood draw was drawn after entering the operating room or after induction of anesthesia; the second blood draw was 30 minutes after induction of anesthesia; the
third blood draw was 30 minutes after going on cardiopulmonary bypass; the fourth blood draw was 30 minutes after separation from cardiopulmonary bypass; and the fifth blood
draw was 24 hours after the end of the procedure. SD, Standard deviation.
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Dfor patients with vasoplegia and this would be expected
because vasoplegic patients had all received vasopressin bo-
luses at the time of this blood draw and most of those
without vasoplegia had not received boluses of vasopressin.
Overall, in this population of patients with right-sided
congenital heart disease, vasopressin levels initially were
low, increasing slightly after the onset of anesthesia,
increasing dramatically after the onset of CPB, and subse-
quently decreasing after surgery. This is consistent with
the vasopressin response in other populations of adult car-
diac surgical patients.10 This also is consistent with the
vasopressin response in children undergoing cardiac sur-
gery requiring CPB: levels have been shown to increase
while on bypass, stay high for 12 hours, begin to decrease
at 24 hours, and return to baseline at 48 hours. Hypotension
was not associated with a vasopressin deficiency in these
children.11
Study limitations included difficulty measuring cardiac
output in this population of patients without pulmonary ar-
tery catheters, which limited the assessment of vasoplegia
to the CPB period. Although there was not a significant dif-
ference in inotropic and vasopressor use in the first 24 hours
after surgery, it was not possible to measure cardiac outputTABLE 3. Demographic variables on cardiopulmonary bypass and outcom
noncongenital patients undergoing left-sided surgical procedures with and
Congenital vasoplegic
patients
Congeni
CPB variables
Hemoglobin (g/dL), mean  SD 11.5  4.3 9
Temperature (Celsius), mean  SD 36.2  0.8 3
Glucose range (mg/dL), mean  SD 97-227
128  35 1
Insulin infusion, N (%) 1 (25%)
Postoperative outcomes
Mortality, N (%) 0
CVA, N (%) 0
Renal failure, N (%) 0
MI, N (%) 0
Respiratory failure, N (%) 0
Infection, N (%) 0
SD, Standard deviation; N, number of patients; CVA, cerebral vascular accident; MI, myo
The Journal of Thoracic and Caor systemic vascular resistance, making a definitive diag-
nosis of vasoplegia not possible. Further work examining
cardiac output with noninvasive methods after surgery is
needed. Another limitation was being unable to differen-
tiate between endogenous and exogenous vasopressin.
The vasoplegic patients had higher levels of vasopressin
on CPB, but this likely was owing to the administration of
vasopressin. Therefore, the levels of endogenous vaso-
pressin in these patients are unknown and it is unknown if
the levels were different compared with the nonvasoplegic
patients. A third limitation was the difference in age be-
tween the congenital heart disease patients and the patients
undergoing left-sided cardiac surgery. Although age alone
does not appear to be a strong risk factor for the develop-
ment of vasoplegia, this is a confounder. The mean age of
the congenital patient population was 31.2 years, and it is
difficult to find a population of patients without congenital
heart disease undergoing cardiac surgery at this age.
In conclusion, this study of 20 patients with right-sided
congenital heart disease showed an incidence of vasoplegia
of 20%, twice the incidence found in our left-sided aortic
valve population. Plasma vasopressin levels were not
different in vasoplegic versus nonvasoplegic patients, ande data for the congenital patients with and without vasoplegia and the
without vasoplegia
tal nonvasoplegic
patients
Left-sided vasoplegic
patients
Left-sided nonvasoplegic
patients
.8  1.4 10.3  0.9 9.2  1.4
6.3  0.6 35.8  1.1 35.0  1.6
93-300
28  44
116-174
142  18
79-323
128  26
4 (25%) 1 (17%) 11 (20%)
0 0 0
0 1 (17%) 0
0 0 1 (2%)
0 0 0
1 (6%) 0 1 (2%)
1 (6%) 0 1 (2%)
cardial infarction.
rdiovascular Surgery c Volume 148, Number 2 629
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Dthe vasopressin response to cardiac surgery was similar to
other cardiac surgical populations with levels beginning
low, increasing slightly after the onset of anesthesia,
increasing dramatically after the onset of CPB, and subse-
quently decreasing after surgery. This study provides
insight into the incidence of vasoplegia in this special car-
diac surgical population of patients with right-sided
congenital heart disease and suggests areas for further clin-
ical investigations in these patients.References
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